Delisting of Securities of Pingtan Marine Enterprise Ltd.; SRAX, Inc.; SVB Financial Group; Signature Bank; Codiak BioSciences, Inc.; PLx Pharma Inc.; Virgin Orbit Holdings, Inc.; Kalera Public Limited Company; Pear Therapeutics, Inc.; and Intelligent Medi
28 Aprile 2023 - 10:05PM
The Nasdaq Stock Market announced today that it
will delist the ordinary shares of Pingtan Marine Enterprise Ltd.
Pingtan Marine Enterprise Ltd. securities were suspended on March
1, 2023, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist
the Class A common stock of SRAX, Inc. SRAX, Inc. securities were
suspended on March 9, 2023, and have not traded on Nasdaq since
that time.
Nasdaq also announced today that it will delist
the common stock and preferred stock of SVB Financial Group. SVB
Financial Group securities were suspended on March 28, 2023, and
have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist
the common stock and preferred stock of Signature Bank. Signature
Bank securities were suspended on March 28, 2023, and have not
traded on Nasdaq since that time.
Nasdaq also announced today that it will delist
the common stock of Codiak BioSciences, Inc. Codiak BioSciences,
Inc. securities were suspended on April 5, 2023, and have not
traded on Nasdaq since that time.
Nasdaq also announced today that it will delist
the common stock of PLx Pharma Inc. PLx Pharma Inc. securities were
suspended on April 13, 2023, and have not traded on Nasdaq since
that time.
Nasdaq also announced today that it will delist
the common stock and warrant of Virgin Orbit Holdings, Inc. Virgin
Orbit Holdings, Inc. securities were suspended on April 13, 2023,
and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist
the ordinary shares and warrant of Kalera Public Limited Company.
Kalera Public Limited Company securities were suspended on April
17, 2023, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist
the Class A common stock and warrant of Pear Therapeutics, Inc.
Pear Therapeutics, Inc. securities were suspended on April 19,
2023, and have not traded on Nasdaq since that time.
Nasdaq also announced today that it will delist
the Class A common stock, warrant, and unit of Intelligent Medicine
Acquisition Corp. Intelligent Medicine Acquisition Corp. securities
were suspended on April 27, 2023, and have not traded on Nasdaq
since that time.
Nasdaq will file a Form 25 with the Federal
Deposit Insurance Corporation (FDIC) to complete the delisting of
Signature Bank and with the U.S. Securities and Exchange Commission
to complete the delisting of all other companies listed in this
release. The delistings become effective ten days after the Form 25
is filed. For news and additional information about the companies,
including the basis for the delisting and whether the companies’
securities are trading on another venue, please review the
companies’ public filings, contact the FDIC (in the case of the
Signature Bank), or contact the companies directly in the case of
the remaining companies listed in this release.
For more information about
The Nasdaq Stock Market, visit the Nasdaq Web site at
http://www.nasdaq.com. Nasdaq’s rules governing the
delisting of securities can be found in the Nasdaq Rule 5800
Series, available on the Nasdaq Web site:
https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.
Grafico Azioni Nasdaq (NASDAQ:NDAQ)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Nasdaq (NASDAQ:NDAQ)
Storico
Da Apr 2023 a Apr 2024